News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Daily News Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows Todd Neale September 25, 2024
News Conference News ESC 2024 Polypills Show Promise in Diverse Hypertensive Patient Groups L.A. McKeown August 31, 2024
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023
News Daily News Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show Caitlin E. Cox April 19, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Daily News Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints L.A. McKeown June 06, 2022
News Daily News Diet Drinks May Help With Weight Loss and Cardiometabolic Control L.A. McKeown March 17, 2022
News Daily News Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension Caitlin E. Cox February 11, 2022
News Daily News CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes L.A. McKeown November 01, 2021
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Daily News Renal Denervation a Third Option for Hypertension, European Experts Say Todd Neale September 17, 2021
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021